This half-day program is designed for scientists/investigators, students and clinicians with an interest in diabetes.
This conference will focus on recent data on the clinical manifestations of SARS-CoV2 infection, with particular emphasis on the interactions and potential metabolic/genetic mechanistic links relating to susceptibility and clinical outcomes in patients with obesity and pre-existing diabetes. Additional focus areas will include novel treatment paradigms for diabetes in the COVID-19 era, and a look forward towards novel antiviral therapies.
As in the past, emphasis will be on the presentation of new and unpublished data, and on vigorous interactions among the audience and speakers.
Tuition is free for all. CME credits available.